Clinical usefulness of 3α-androstanediolglucuronide in hirsute women;Die klinische Wertigkeit von 3α-Androstanediol-Glucuronid bei hirsuten Frauen

Wiener Klinische Wochenschrift

Volumn 109, Issue 23, 1997, Pages 919-921

  Joura, Elmar A ^a,c   Sator, Michael O ^a   Geusau, Alexandra ^b   Zeisler, Harald ^a   Söregi, Gabor ^c   Huber, Johannes C ^a  

^a Universitätsklinik für Frauenheilkunde

^b Universitatsklinik fur Dermatologie   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

3 androstanediol glucuronide; Hirsutism

Indexed keywords

ANDROSTANEDIOL; ANDROSTENEDIONE; GLUCURONIDE; PRASTERONE SULFATE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE;

ADULT; ANDROGEN SYNTHESIS; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; FEMALE; HIRSUTISM; HUMAN; MAJOR CLINICAL STUDY; PREMENOPAUSE; STEROIDOGENESIS; TESTOSTERONE BLOOD LEVEL; VIRILIZATION;

ADOLESCENT; ADULT; ANDROGENS; ANDROSTANE-3,17-DIOL; BODY MASS INDEX; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIRSUTISM; HUMANS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0031566057     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ferriman D, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21: 1440-1447
2. Fruzzetti F, de Lorenzo D, Parrini D, Ricci C (1994) Effects of finasteride, a 5α-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women. J Clin Endocrinol Metab 79: 831-835
3. Giagulli VA, Giorgino R, Vermeiden A (1991) Is plasma 5α-androstane-3α, 17β-diol-glucuronide a biochemical marker of hirsutism in women? J Steroid Biochem Molec Biol 39: 55-61
4. Horton R, Hawks D, Lobo RA (1982) 3α-17β-androstane-diol-glucuronide in plasma: a marker of androgen action in idiopathic hirsutism. J Clin Invest 69: 1203-1206
5. Khoury MY, Baracat EC. Pardini DP, Vieira JGH. de Lima GR (1994) Serum levels of androstanediol glucuronide. total testosterone and free testosterone in hirsute women. Fertil Steril 62: 76-80
6. Kirschner A. Samojlik E, Szmal E (1987) Clinical usefulness of plasma androstanediol glucuronide measurements in women with idiopathic hirsutism. J Clin Endocrinol Metab 65: 597-601
7. Lobo RA, Paul WL, Goebelsmann U (1981) Dehydroepiandrosterone sulfate as an indicator of adrenal function. Obstet Gynecol 57: 69-73
8. Lobo RA (1991) Androgen excess. In: Mishell DR, Davajan V, Lobo RA (eds) Infertilty, contraception and reproductive endrocrinology, 3rd edn. Blackwell ScientificPublications, Boston, pp 422-446
9. Rittmaster RS, Zwicker H, Thompson DL, Konok G, Norman RW (1993) Androstanediol glucuronide production in human liver, prostate and skin. Evidence for the importance of the liver in 5a-reduced androgen metabolism. J Clin Endocrinol Metab 76: 977-982
10. Serafini P, Ablan F, Lobo RA (1985) 5cc-reductase activity in the genital skin If hirsute women. J Clin Endocrinol Metab 60: 349-355
11. Serafini P, Lobo RA ( 1985) Increased 5a-reductase activity in idiopathic hirsutism. Fertil Steril 43:74-78
12. Vermeulen A, Giagulli VA (1991) Physiopathology of plasma androstanediolglucuronide. J Steroid Biochem Molec Biol 39: 829-833
13. Neu in Osterreich zugelassene Arzneimittelspezialitäten und neue Erkenntnisse über schon länger im Handel befindliche Arzneispezialitäten (1994) Proscar-Filmtabletten (Finasterid, MSD). Wien Klin Wochenschr 106: 327-332